These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 26368809

  • 1. Quinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis.
    Baranyi A, Meinitzer A, Breitenecker RJ, Amouzadeh-Ghadikolai O, Stauber R, Rothenhäusler HB.
    PLoS One; 2015; 10(9):e0137022. PubMed ID: 26368809
    [Abstract] [Full Text] [Related]

  • 2. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
    Comai S, Cavalletto L, Chemello L, Bernardinello E, Ragazzi E, Costa CV, Bertazzo A.
    Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
    [Abstract] [Full Text] [Related]

  • 3. A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection.
    Baranyi A, Meinitzer A, Stepan A, Putz-Bankuti C, Breitenecker RJ, Stauber R, Kapfhammer HP, Rothenhäusler HB.
    Psychother Psychosom; 2013 Jan; 82(5):332-40. PubMed ID: 23942342
    [Abstract] [Full Text] [Related]

  • 4. Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
    Baranyi A, Meinitzer A, Putz-Bankuti C, Stauber R, Kapfhammer HP, Rothenhäusler HB.
    Psychosom Med; 2014 Apr; 76(3):197-207. PubMed ID: 24608038
    [Abstract] [Full Text] [Related]

  • 5. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [Abstract] [Full Text] [Related]

  • 6. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M.
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [Abstract] [Full Text] [Related]

  • 7. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
    Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Meltzer H.
    Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
    [Abstract] [Full Text] [Related]

  • 8. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
    Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M.
    J Clin Psychopharmacol; 2002 Feb; 22(1):86-90. PubMed ID: 11799348
    [Abstract] [Full Text] [Related]

  • 9. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Andrzej K.
    Psychiatr Pol; 2006 Feb; 40(4):799-808. PubMed ID: 17068951
    [Abstract] [Full Text] [Related]

  • 10. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
    Małyszczak K, Inglot M, Frydecka D, Hadryś T, Pawłowski T.
    Adv Clin Exp Med; 2019 Sep; 28(9):1217-1222. PubMed ID: 30811903
    [Abstract] [Full Text] [Related]

  • 11. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J, Karila L, Costisella O, Canva V.
    Encephale; 2005 Sep; 31(3):349-57. PubMed ID: 16142050
    [Abstract] [Full Text] [Related]

  • 12. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
    Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH.
    Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
    [Abstract] [Full Text] [Related]

  • 13. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z, Delić D, Marić NP, Vuković O, Jašović-Gašić M.
    Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
    [Abstract] [Full Text] [Related]

  • 14. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A, Quarantini LC, Sampaio AS, Lyra AC, Parise CL, Paraná R, de Oliveira IR, Koenen KC, Miranda-Scippa A, Guindalini C.
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F, Janssen G, Martin G, Lorenz R, Loeschke K, Soyka M, Folwaczny C, Schaefer M.
    Aliment Pharmacol Ther; 2009 Nov 15; 30(10):1049-59. PubMed ID: 19691667
    [Abstract] [Full Text] [Related]

  • 16. Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.
    Maddock C, Baita A, Orrù MG, Sitzia R, Costa A, Muntoni E, Farci MG, Carpiniello B, Pariante CM.
    J Psychopharmacol; 2004 Mar 15; 18(1):41-6. PubMed ID: 15107183
    [Abstract] [Full Text] [Related]

  • 17. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
    Neri S, Pulvirenti D, Bertino G.
    Clin Drug Investig; 2006 Mar 15; 26(11):655-62. PubMed ID: 17163300
    [Abstract] [Full Text] [Related]

  • 18. Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha.
    Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Ferlito L, Rampello L.
    Neuropsychobiology; 1998 Mar 15; 37(2):93-7. PubMed ID: 9566274
    [Abstract] [Full Text] [Related]

  • 19. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C.
    Amodio P, De Toni EN, Cavalletto L, Mapelli D, Bernardinello E, Del Piccolo F, Bergamelli C, Costanzo R, Bergamaschi F, Poma SZ, Chemello L, Gatta A, Perini G.
    J Affect Disord; 2005 Jan 15; 84(1):93-8. PubMed ID: 15620390
    [Abstract] [Full Text] [Related]

  • 20. Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.
    Murakami Y, Ishibashi T, Tomita E, Imamura Y, Tashiro T, Watcharanurak K, Nishikawa M, Takahashi Y, Takakura Y, Mitani S, Fujigaki H, Ohta Y, Kubo H, Mamiya T, Nabeshima T, Kim HC, Yamamoto Y, Saito K.
    Sci Rep; 2016 Jul 20; 6():29920. PubMed ID: 27436416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.